Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction.

Changes in prescription patterns before and after reporting of the Ezetimibe and Simvastatin in Hypercholesterolemia Enhances Atherosclerosis Regression trial (ENHANCE) results and expected effects on low-density lipoprotein-cholesterol reduction. J Clin Lipidol. 2012 Mar-Apr; 6(2):180-91.

View in: PubMed

subject areas

Adolescent
Adult
Aged
Atherosclerosis
Azetidines
Carotid Intima-Media Thickness
Cholesterol, LDL
Clinical Trials as Topic
Drug Combinations
Drug Prescriptions
Ezetimibe
Female
Humans
Hypercholesterolemia
Longitudinal Studies
Male
Middle Aged
Research Design
Retrospective Studies
Simvastatin
Time Factors
Young Adult

authors with profiles

Michael H. Davidson